The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MagnetisMM-32: A phase 3 randomized study of elranatamab vs EPd, PVd, or Kd in patients with relapsed or refractory multiple myeloma (RRMM) and prior anti-CD38–directed therapy.
 
Steven Schuster
No Relationships to Disclose
 
Saulius Girnius
No Relationships to Disclose
 
Rayan Kaedbey
No Relationships to Disclose
 
Paola Ochoa
No Relationships to Disclose
 
Ludek Pour
No Relationships to Disclose
 
Ronan Le Calloch
No Relationships to Disclose
 
Tobias S. Slørdahl
Honoraria - Abbvie; Johnson & Johnson/Janssen; Pfizer; Takeda
Consulting or Advisory Role - BMS Norway (Inst); GlaxoSmithKline; Johnson & Johnson/Janssen; Menarini Group; Pfizer; Sanofi
 
Ann De Becker
No Relationships to Disclose
 
Fangxin Hong
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Margaret Hoyle
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Anne Yver
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Gregory Finn
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Thomas Chalopin
Consulting or Advisory Role - Johnson & Johnson/Janssen; Pfizer; Sanofi